XML 101 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative and Other Fair Value Instruments
12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Derivatives and Fair Value [Text Block]
9.
Derivative and Other Fair Value Instruments
The valuation of financial instruments requires the Company to make estimates and judgments that affect the fair value of the instruments. The Company, where possible, bases the fair values of its financial instruments, including its derivative instruments, on listed market prices and third party quotes. Where these are not available, the Company bases its estimates on current instruments with similar terms and maturities or on other factors relevant to the financial instruments.
The carrying values of the Company’s mortgage notes payable and unsecured debt (including its line of credit) were approximately $5.2 billion and $5.6 billion, respectively, at December 31, 2013. The fair values of the Company’s mortgage notes payable and unsecured debt (including its line of credit) were approximately $5.1 billion (Level 2) and $5.9 billion (Level 2), respectively, at December 31, 2013. The carrying values of the Company’s mortgage notes payable and unsecured notes were approximately $3.9 billion and $4.6 billion, respectively, at December 31, 2012. The fair values of the Company’s mortgage notes payable and unsecured notes were approximately $4.3 billion (Level 2) and $5.2 billion (Level 2), respectively, at December 31, 2012. The fair values of the Company’s financial instruments (other than mortgage notes payable, unsecured notes, lines of credit, derivative instruments and investment securities), including cash and cash equivalents and other financial instruments, approximate their carrying or contract values.
In the normal course of business, the Company is exposed to the effect of interest rate changes. The Company seeks to manage these risks by following established risk management policies and procedures including the use of derivatives to hedge interest rate risk on debt instruments. The Company may also use derivatives to manage its exposure to foreign exchange rates or manage commodity prices in the daily operations of the business.
The following table summarizes the Company’s consolidated derivative instruments at December 31, 2013 (dollar amounts are in thousands):
 
Forward
Starting
Swaps (1)
Current Notional Balance
$
400,000

Lowest Possible Notional
$
400,000

Highest Possible Notional
$
400,000

Lowest Interest Rate
2.125
%
Highest Interest Rate
3.230
%
Earliest Maturity Date
2024

Latest Maturity Date
2024



(1)
Forward Starting Swaps – Designed to partially fix the interest rate in advance of a planned future debt issuance. These swaps have mandatory counterparty terminations in 2015, and are targeted to 2014 issuances.

In April 2013, the Company's remaining fair value hedges matured.

In June 2011, the Company's remaining development cash flow hedge matured.

A three-level valuation hierarchy exists for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels are defined as follows:

Level 1 – Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 – Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 – Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The Company’s derivative positions are valued using models developed by the respective counterparty as well as models developed internally by the Company that use as their basis readily observable market parameters (such as forward yield curves and credit default swap data). Employee holdings other than Common Shares within the supplemental executive retirement plan (the “SERP”) are valued using quoted market prices for identical assets and are included in other assets and other liabilities on the consolidated balance sheet. The Company’s investment securities are valued using quoted market prices or readily available market interest rate data. Redeemable Noncontrolling Interests – Operating Partnership/Redeemable Limited Partners are valued using the quoted market price of Common Shares. The fair values disclosed for mortgage notes payable and unsecured debt (including its line of credit) were calculated using indicative rates provided by lenders of similar loans in the case of mortgage notes payable and the private unsecured debt (including its line of credit) and quoted market prices for each underlying issuance in the case of the public unsecured notes.
The following tables provide a summary of the fair value measurements for each major category of assets and liabilities measured at fair value on a recurring basis and the location within the accompanying consolidated balance sheets at December 31, 2013 and 2012, respectively (amounts in thousands):
 
 
 
 
 
 
Fair Value Measurements at Reporting Date Using
 
 
 
 
 
 
Quoted Prices in
 
 
 
 
 
 
 
 
 
 
Active Markets for
 
Significant Other
 
Significant
 
 
Balance Sheet
 
 
 
Identical Assets/Liabilities
 
Observable Inputs
 
Unobservable Inputs
Description
 
Location
 
12/31/2013
 
(Level 1)
 
(Level 2)
 
(Level 3)
Assets
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
   Interest Rate Contracts:
 
 
 
 
 
 
 
 
 
      Forward Starting Swaps
 
Other Assets
 
$
18,712

 
$

 
$
18,712

 
$

Supplemental Executive Retirement Plan
Other Assets
 
83,845

 
83,845

 

 

Total
 
 
 
$
102,557

 
$
83,845

 
$
18,712

 
$

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
Supplemental Executive Retirement Plan
Other Liabilities
 
$
83,845

 
$
83,845

 
$

 
$

Total
 
 
 
$
83,845

 
$
83,845

 
$

 
$

 
 
 
 
 
 
 
 
 
 
 
Redeemable Noncontrolling Interests –
 
 
 
 
 
 
 
 
 
   Operating Partnership/Redeemable
 
 
 
 
 
 
 
 
 
      Limited Partners
Mezzanine
 
$
363,144

 
$

 
$
363,144

 
$



 
 
 
 
 
 
Fair Value Measurements at Reporting Date Using
 
 
 
 
 
 
Quoted Prices in
 
 
 
 
 
 
 
 
 
 
Active Markets for
 
Significant Other
 
Significant
 
 
Balance Sheet
 
 
 
Identical Assets/Liabilities
 
Observable Inputs
 
Unobservable Inputs
Description
 
Location
 
12/31/2012
 
(Level 1)
 
(Level 2)
 
(Level 3)
Assets
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
   Interest Rate Contracts:
 
 
 
 
 
 
 
 
 
      Fair Value Hedges
 
Other Assets
 
$
1,523

 
$

 
$
1,523

 
$

Supplemental Executive Retirement Plan
Other Assets
 
70,655

 
70,655

 

 

Available-for-Sale Investment Securities
Other Assets
 
2,214

 
2,214

 

 

Total
 
 
 
$
74,392

 
$
72,869

 
$
1,523

 
$

 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
   Interest Rate Contracts:
 
 
 
 
 
 
 
 
 
      Forward Starting Swaps
Other Liabilities
 
$
44,050

 
$

 
$
44,050

 
$

Supplemental Executive Retirement Plan
Other Liabilities
 
70,655

 
70,655

 

 

Total
 
 
 
$
114,705

 
$
70,655

 
$
44,050

 
$

 
 
 
 
 
 
 
 
 
 
 
Redeemable Noncontrolling Interests –
 
 
 
 
 
 
 
 
 
   Operating Partnership/Redeemable
 
 
 
 
 
 
 
 
 
      Limited Partners
Mezzanine
 
$
398,372

 
$

 
$
398,372

 
$


The following tables provide a summary of the effect of fair value hedges on the Company’s accompanying consolidated statements of operations and comprehensive income for the years ended December 31, 2013, 2012 and 2011, respectively (amounts in thousands):

December 31, 2013
 
Location of Gain/(Loss) Recognized in Income
on Derivative
 
Amount of Gain/(Loss) Recognized in Income
on Derivative
 
 
 
Income Statement Location of Hedged
Item Gain/(Loss)
 
Amount of Gain/(Loss)Recognized in Income
on Hedged Item
Type of Fair Value Hedge
 
 
 
Hedged Item
 
 
Derivatives designated as hedging instruments:
 
 
 
 

 
 
 
 
 
 

Interest Rate Contracts:
 
 
 
 

 
 
 
 
 
 

Interest Rate Swaps
 
Interest expense
 
$
(1,523
)
 
Fixed rate debt
 
Interest expense
 
$
1,523

Total
 
 
 
$
(1,523
)
 
 
 
 
 
$
1,523


December 31, 2012
 
Location of Gain/(Loss) Recognized in Income
on Derivative
 
Amount of Gain/(Loss) Recognized in Income
on Derivative
 
 
 
Income Statement Location of Hedged
Item Gain/(Loss)
 
Amount of Gain/(Loss)Recognized in Income
on Hedged Item
Type of Fair Value Hedge
 
 
 
Hedged Item
 
 
Derivatives designated as hedging instruments:
 
 
 
 

 
 
 
 
 
 

Interest Rate Contracts:
 
 
 
 

 
 
 
 
 
 

Interest Rate Swaps
 
Interest expense
 
$
(7,448
)
 
Fixed rate debt
 
Interest expense
 
$
7,448

Total
 
 
 
$
(7,448
)
 
 
 
 
 
$
7,448


December 31, 2011
 
Location of Gain/(Loss) Recognized in Income
on Derivative
 
Amount of Gain/(Loss) Recognized in Income
on Derivative
 
 
 
Income Statement Location of Hedged
Item Gain/(Loss)
 
Amount of Gain/(Loss)Recognized in Income
on Hedged Item
Type of Fair Value Hedge
 
 
 
Hedged Item
 
 
Derivatives designated as hedging instruments:
 
 
 
 

 
 
 
 
 
 

Interest Rate Contracts:
 
 
 
 

 
 
 
 
 
 

Interest Rate Swaps
 
Interest expense
 
$
(3,549
)
 
Fixed rate debt
 
Interest expense
 
$
3,549

Total
 
 
 
$
(3,549
)
 
 
 
 
 
$
3,549



The following tables provide a summary of the effect of cash flow hedges on the Company’s accompanying consolidated statements of operations and comprehensive income for the years ended December 31, 2013, 2012 and 2011, respectively (amounts in thousands):

 
 
Effective Portion
 
Ineffective Portion
December 31, 2013
 
Amount of
Gain/(Loss) Recognized in OCI
on Derivative
 
Location of Gain/(Loss)
Reclassified from Accumulated OCI
into Income
 
Amount of Gain/(Loss)
Reclassified from Accumulated OCI
into Income
 
Location of
Gain/(Loss) Recognized in Income
on Derivative
 
Amount of Gain/(Loss)
Reclassified from Accumulated OCI
into Income
Type of Cash Flow Hedge
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 

 
 
 
 

 
 
 
 

Interest Rate Contracts:
 
 

 
 
 
 

 
 
 
 

Forward Starting Swaps/Treasury Locks
 
$
18,771

 
Interest expense
 
$
(20,141
)
 
N/A
 
$

Total
 
$
18,771

 
 
 
$
(20,141
)
 
 
 
$


 
 
Effective Portion
 
Ineffective Portion
December 31, 2012
 
Amount of
Gain/(Loss) Recognized in OCI
on Derivative
 
Location of Gain/(Loss)
Reclassified from Accumulated
OCI
into Income
 
Amount of Gain/(Loss)
Reclassified from Accumulated
OCI
into Income
 
Location of
Gain/(Loss) Recognized in Income
on Derivative
 
Amount of Gain/(Loss)
Reclassified from Accumulated
OCI
into Income
Type of Cash Flow Hedge
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Interest Rate Contracts:
 
 
 
 
 
 
 
 
 
 
Forward Starting Swaps/Treasury Locks
 
$
(11,772
)
 
Interest expense
 
$
(14,678
)
 
N/A
 
$

Total
 
$
(11,772
)
 
 
 
$
(14,678
)
 
 
 
$


 
 
Effective Portion
 
Ineffective Portion
December 31, 2011
 
Amount of
Gain/(Loss) Recognized in OCI
on Derivative
 
Location of Gain/(Loss)
Reclassified from Accumulated
OCI
into Income
 
Amount of Gain/(Loss)
Reclassified from Accumulated
OCI
into Income
 
Location of
Gain/(Loss) Recognized in Income
on Derivative
 
Amount of Gain/(Loss)
Reclassified from Accumulated
OCI
into Income
Type of Cash Flow Hedge
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Interest Rate Contracts:
 
 
 
 
 
 
 
 
 
 
Forward Starting Swaps/Treasury Locks
 
$
(145,090
)
 
Interest expense
 
$
(4,343
)
 
Interest expense
 
$
(170
)
Development Interest Rate Swaps/Caps
 
1,322

 
Interest expense
 

 
N/A
 

Total
 
$
(143,768
)
 
 
 
$
(4,343
)
 
 
 
$
(170
)

As of December 31, 2013 and 2012, there were approximately $155.8 million and $194.7 million in deferred losses, net, included in accumulated other comprehensive (loss), respectively, related to derivative instruments. Based on the estimated fair values of the net derivative instruments at December 31, 2013, the Company may recognize an estimated $21.8 million of accumulated other comprehensive (loss) as additional interest expense during the year ending December 31, 2014.
    
In April 2013, the Company paid approximately $44.7 million to settle three forward starting swaps in conjunction with the issuance of $500.0 million of ten-year fixed rate public notes. The accrued interest of $0.7 million was recorded as interest expense. The remaining amount of $44.0 million will be deferred as a component of accumulated other comprehensive (loss) and recognized as an increase to interest expense over the approximate term of the notes. 

In December 2011, the Company paid approximately $153.2 million to settle various forward starting swaps in conjunction with the issuance of $1.0 billion of ten-year fixed rate public notes. The ineffective portion of $0.2 million and accrued interest of $5.9 million were recorded as interest expense. The remaining amount of $147.1 million will be deferred as a component of accumulated other comprehensive (loss) and is recognized as an increase to interest expense over the approximate term of the notes.
The following tables set forth the maturity, amortized cost, gross unrealized gains and losses, book/fair value and interest and other income of the various investment securities held as of December 31, 2013 and 2012, respectively (amounts in thousands):
 
 
 
 
Other Assets
 
 
December 31, 2013
 
Maturity
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Book/
Fair Value
 
Interest and
Other Income
Security
 
 
 
 
 
 
Available-for-Sale Investment Securities
 
N/A
 
$

 
$

 
$

 
$

 
$
2,122

Total
 
 
 
$

 
$

 
$

 
$

 
$
2,122


 
 
 
 
Other Assets
 
 
December 31, 2012
 
Maturity
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Book/
Fair Value
 
Interest and
Other Income
Security
 
 
 
 
 
 
Available-for-Sale Investment Securities
 
N/A
 
$
675

 
$
1,539

 
$

 
$
2,214

 
$

Total
 
 
 
$
675

 
$
1,539

 
$

 
$
2,214

 
$



During the year ended December 31, 2013, the Company sold all of its investment securities, receiving proceeds of approximately $2.8 million, and recorded a $2.1 million realized gain on sale (specific identification) which is included in interest and other income.